Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MODULATE for diarrhoea in stable ulcerative colitis
ISRCTN16086699Phase 3Terminated
- Sponsor
- University of Leeds
- Start
- Apr 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of amitriptyline, loperamide and ondansetron in autoimmune colitis (5 arms), sponsored by University of Leeds. Primary endpoints: Improvement in diarrhoea at 8 weeks and Disease-specific quality of life at 6 months. Started Apr 2021; status: terminated.
02
Drugs
amitriptylineloperamideondansetron
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on ISRCTN16086699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16086699.